Skip to main content
. 2022 May 31;22(3):100313. doi: 10.1016/j.ijchp.2022.100313

Table 1.

Sociodemographic and clinical characteristics (N= 636).

Characteristics n (%)
Sex
 Male 338 (53.1)
 Female 298 (46.9)
Age
 ≤55 years 128 (20.1)
 56-65 223 (35.1)
 ≥ 66 285 (44.8)
Marital Status
 Married/ partnered 489 (76.8)
 Not partnered 147 (23.1)
 p value
Educational level
 Primary 313 (49.2)
 High school or higher 323 (50.8)
Cancer type
 Thoracic 206 (32.4)
 Digestive 247 (38.8)
 Others 183 (28.8)
Histology
 Adenocarcinoma 395 (62.1)
 Others 241 (37.9)
Cancer stage
 Locally advanced 123 (19.3)
 Metastatic disease (IV) 513 (80.7)
Estimated survival
 <18 months 296 (46.5)
 ≥18 months 340 (53.5)
Type of treatment
 Chemotherapy 338 (53.1)
 Chemo+Targeted 90 (14.2)
 Chemo+Immunotherapy 77 (12.1)
 Immunotherapy 46 (7.2)
 Targeted 44 (6.9)
 Others 2 (0.3)